Detailed Narrative
Strategic Shift Towards Specialty Products
Deepak Fertilisers is actively transitioning from commodity to specialty products, with 22% of total revenues now emerging from this segment. This shift is particularly evident in the Crop Nutrition business, where products like Croptek and Bensulf offer unique value propositions. This strategy is enhancing customer stickiness and contributing to improved margins, aligning with India's growth story and providing insulation from global volatility🌐.
Robust Financial Performance in FY25
The company delivered strong financial results in FY25, with full-year operating revenue growing 18% to ₹10,274 crores. EBITDA saw a remarkable 50% increase to ₹1,925 crores, expanding margins to 19%. Net profit more than doubled, growing 102% to ₹945 crores, reflecting effective strategy execution and cost discipline. The Board recommended a 100% dividend, balancing strong performance with ongoing CAPEX plans.
Capital Expenditure and Balance Sheet Strengthening
Deepak Fertilisers is undertaking significant CAPEX, with ₹1,100 crores spent in FY25 and an estimated ₹4,500 crores planned for FY26, primarily for new nitric acid and technical ammonium nitrate capacities. Despite this, net debt reduced by ₹120 crores, and the net debt-to-EBITDA ratio improved to a healthy 1.72x from 2.66x. The company expects peak debt around ₹5,000 crores, with deleveraging commencing post-project commissioning in FY27.
Segmental Performance Overview
The Crop Nutrition Business (CNB) had its strongest Q4, with bulk fertilizers volume growing 68% Y-o-Y and specialty Croptek volume more than doubling. The Mining Chemical (TAN) business saw Q4 volume grow 13% sequentially, with LDAN's B2C revenue share reaching 18%. Industrial Chemicals experienced a 29% Y-o-Y increase in Q4 nitric acid volumes, though IPA volumes declined due to a plant shutdown for process enhancement.
Progress on Key Expansion Projects
The Gopalpur project for Technical Ammonium Nitrate is 75% complete, and the Dahej project for nitric acid is 48% complete. Both projects are on track for commissioning in H2 FY26. These expansions are crucial for import substitution, margin expansion, and deeper market integration, with an expected ROCE of 18-20% once 80-85% utilization is achieved.
Ammonia Cost Structure and LNG Contract
Management clarified that the EBITDA breakeven for ammonia production is around $310-$320 per ton. While gas prices have fluctuated, the full benefits of the long-term Equinor LNG contract are expected to kick in during FY26, which will significantly reduce gas costs and improve profitability. The company's integrated value chain from LNG to downstream products provides a unique competitive advantage.